Literature DB >> 9020380

Inhibition of MHC class I antigen presentation by viral proteins.

K Früh1, K Ahn, P A Peterson.   

Abstract

An essential part of the immune response to viral infections is the recognition and elimination of infected cells by cytotoxic T lymphocytes. For this purpose a display mechanism has evolved which is present in almost all nucleated cells: the major histocompatibility complex class I antigen processing pathway. Both self and foreign antigens are degraded in the cytosol to peptides which are translocated into the endoplasmic reticulum where they are loaded onto MHC class I molecules. Pathogens living inside the cell are evolving under the constant selection pressure of such immune surveillance. As a result such infectious organisms have developed a variety of strategies to prevent their antigens from being presented. Since our understanding of the cell biology of antigen presentation has greatly advanced in recent years, it has now become possible to unravel several of the molecular mechanisms by which viruses interfere with MHC class I antigen presentation. Examples for the interference of viral molecules with components of the MHC class I pathway are presented in this review.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9020380     DOI: 10.1007/s001090050082

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  12 in total

1.  A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation.

Authors:  U Reusch; W Muranyi; P Lucin; H G Burgert; H Hengel; U H Koszinowski
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

2.  The SH3 domain-binding surface and an acidic motif in HIV-1 Nef regulate trafficking of class I MHC complexes.

Authors:  M E Greenberg; A J Iafrate; J Skowronski
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

3.  IFN-inducible p47 GTPases display differential responses to Schistosoma japonicum acute infection.

Authors:  Xuesong Chen; Xiaotang Du; Meijuan Zhang; Donghui Zhang; Minjun Ji; Guanling Wu
Journal:  Cell Mol Immunol       Date:  2009-12-23       Impact factor: 11.530

4.  Toward eliminating HLA class I expression to generate universal cells from allogeneic donors.

Authors:  Hiroki Torikai; Andreas Reik; Frank Soldner; Edus H Warren; Carrie Yuen; Yuanyue Zhou; Denise L Crossland; Helen Huls; Nicholas Littman; Ziying Zhang; Scott S Tykodi; Partow Kebriaei; Dean A Lee; Jeffrey C Miller; Edward J Rebar; Michael C Holmes; Rudolf Jaenisch; Richard E Champlin; Philip D Gregory; Laurence J N Cooper
Journal:  Blood       Date:  2013-06-05       Impact factor: 22.113

Review 5.  Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses.

Authors:  H G Burgert; J H Blusch
Journal:  Virus Genes       Date:  2000       Impact factor: 2.198

6.  Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon gamma-inducible major histocompatibility complex class I expression in chlamydia-infected cells.

Authors:  G Zhong; L Liu; T Fan; P Fan; H Ji
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307

7.  Inhibition of MHC class I is a virulence factor in herpes simplex virus infection of mice.

Authors:  Mark T Orr; Kurt H Edelmann; Jeffrey Vieira; Lawrence Corey; David H Raulet; Christopher B Wilson
Journal:  PLoS Pathog       Date:  2005-09-30       Impact factor: 6.823

8.  Propanil exposure induces delayed but sustained abrogation of cell-mediated immunity through direct interference with cytotoxic T-lymphocyte effectors.

Authors:  James M Sheil; Marc A Frankenberry; Todd D Schell; Kathleen M Brundage; John B Barnett
Journal:  Environ Health Perspect       Date:  2006-07       Impact factor: 9.031

9.  Bacterial toxins and the immune system: show me the in vivo targets.

Authors:  Jorge E Galán
Journal:  J Exp Med       Date:  2005-02-07       Impact factor: 14.307

10.  Natural HLA class I polymorphism controls the pathway of antigen presentation and susceptibility to viral evasion.

Authors:  Danielle Zernich; Anthony W Purcell; Whitney A Macdonald; Lars Kjer-Nielsen; Lauren K Ely; Nihay Laham; Tanya Crockford; Nicole A Mifsud; Mandvi Bharadwaj; Linus Chang; Brian D Tait; Rhonda Holdsworth; Andrew G Brooks; Stephen P Bottomley; Travis Beddoe; Chen Au Peh; Jamie Rossjohn; James McCluskey
Journal:  J Exp Med       Date:  2004-06-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.